Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00893074 · ClinicalTrials.gov registry record · Phase 1
The Effect of Prescription Medications in Marijuana Users
A Phase 1 study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Phase 1
- Development phase
- 24
- Enrollment target
NCT00893074: Completed Phase 1 study, sponsored by Johns Hopkins University.
NCT00893074 is a Phase 1 study that has completed, run by Johns Hopkins University. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00893074, a Phase 1 study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 24 participants
- Enrollment target
Study Summary
A subset of heavy marijuana users have trouble quitting marijuana use and the number of those seeking treatment for problems related to marijuana is increasing. The purpose of this research study is to investigate whether dronabinol can reduce withdrawal effects associated with stopping marijuana use, if dronabinol can reduce the rewarding effects of smoked marijuana, and whether there are any cognitive performance deficits associated with dronabinol doses that produce such effects.
Interventions
- DRUG Placebo
- DRUG Dronabinol 30mg/day
- DRUG Dronabinol 60mg/day
- DRUG Dronabinol 120mg/day
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2009-04 |
| Est. Completion | 2011-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00893074
The ClinicalTrials.gov registry entry for NCT00893074 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT00893074 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00893074 about?
NCT00893074 is a clinical study titled "The Effect of Prescription Medications in Marijuana Users". A subset of heavy marijuana users have trouble quitting marijuana use and the number of those seeking treatment for problems related to marijuana is increasing. The purpose of this research study is to investigate whether dronabinol can reduce withdrawal effects associated with stopping marijuana us...
What is the current status of trial NCT00893074?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 24 participants. The study started on 2009-04. Estimated completion is 2011-10.
What interventions are being tested in trial NCT00893074?
The interventions under investigation include: Placebo (DRUG), Dronabinol 30mg/day (DRUG), Dronabinol 60mg/day (DRUG), Dronabinol 120mg/day (DRUG).
Who is sponsoring clinical trial NCT00893074?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.